Breastcancer.org, Ardmore, PA
Marisa C. Weiss , Stephanie Kjelstrom , Meghan Buckley , Adam Leitenberger , Melissa Jenkins , Katherine Aliano Ruiz , Alexandra Berk , Donna-Marie Manasseh , Sharon Larson
Background: A current cancer diagnosis is a risk factor for serious COVID-19 complications (CDC). In addition, the pandemic has caused major disruptions in medical care and support networks, resulting in treatment delays, limited access to doctors, worsening health disparities, social isolation; and driving higher utilization of telemedicine and online resources. Breastcancer.org has experienced a sustained surge of new and repeat users seeking urgent information and support. To better understand these unmet needs, we conducted a survey of the Breastcancer.org Community. Methods: Members of the Breastcancer.org Community were invited to complete a survey on the effects of the COVID-19 pandemic on their breast cancer care, including questions on demographics, comorbidities (including lung, heart, liver and kidney disease, asthma, diabetes, obesity, and other chronic health conditions); care delays, anxiety due to COVID-related care delays, use of telemedicine, and satisfaction with care during COVID. The survey was conducted between 4/27/2020-6/1/2020 using Survey Monkey. Results were tabulated and compared by chi square test. A p-value of 0.05 is considered significant. Data were analyzed using Stata 16.0 (Stata Corp., Inc, College Station, TX). Results: Our analysis included 568 breast cancer patients of whom 44% had ≥1 other comorbidities associated with serious COVID-19 complications (per CDC) and 37% had moderate to extreme anxiety about contracting COVID. This anxiety increased with the number of comorbidities (p=0.021), age (p=0.040), and with a current breast cancer diagnosis (p=0.011) (see table). Anxiety was significantly higher in those currently diagnosed, ≥65, or with ≥3 other comorbidities, compared to those diagnosed in the past, age <44, or without other comorbidities. Conclusions: Our survey reveals that COVID-related anxiety is prevalent at any age regardless of overall health status, but it increased with the number of other comorbidities, older age, and a current breast cancer diagnosis. Thus, reported anxiety is proportional to the risk of developing serious complications from COVID. Current breast cancer patients of all ages—especially with other comorbidities—require emotional support, safe access to their providers, and prioritization for vaccination.
Anxiety Level | P-value | |||
---|---|---|---|---|
No Anxiety | Slightly/Somewhat | Moderately/Extremely | ||
Breast Cancer | 0.011 | |||
Past | 33 (11.6) | 164 (58.0) | 86 (30.4) | |
Current | 28 (10.0) | 134 (47.5) | 120 (42.5) | |
Other Comorbidities | 0.021 | |||
0 | 43 (13.5) | 170 (53.5) | 105 (33.0) | |
1 | 14 (8.1) | 99 (57.2) | 60 (34.7) | |
2 | 3 (5.2) | 24 (41.4) | 31 (53.5) | |
3 | 1 (9.1) | 3 (27.3) | 7 (63.6) | |
4 | 0 (0) | 2 (40.0) | 3 (60.0) | |
Age | 0.04 | |||
25-34 | 0 (0) | 4 (57.1) | 3 (42.9) | |
35-44 | 6 (12.0) | 31 (62.0) | 13 (26.0) | |
45-54 | 19 (14.1) | 74 (54.8) | 42 (31.1) | |
55-64 | 25 (13.7) | 96 (52.5) | 62 (33.9) | |
65+ | 11 (5.8) | 92 (49.0) | 85 (45.2) |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Quality Care Symposium
First Author: Youmin Cho
2023 ASCO Annual Meeting
First Author: Edison Tsui
2022 ASCO Quality Care Symposium
First Author: Martine C. Maculaitis
2021 ASCO Annual Meeting
First Author: Scott David Ramsey